Nivolumab (NIVO) plus (+) chemotherapy (chemo) or ipilimumab (IPI) vs chemo as 1L treatment for advanced esophageal squamous cell carcinoma (ESCC): First comprehensive biomarker analyses from CheckMate 648

Journal

Journal of Clinical Oncology

Series/Report No.

Journal of Clinical Oncology

Journal Volume

42

Journal Issue

3

Start Page

Article number 252

Date Issued

2024-01-01

Author(s)

Lei M.

Doki, Yuichiro

Kitagawa, Yuko

Kato, Ken

Chau, Ian

Yao, Jin

Xu, Jianming

Wyrwicz, Lucjan S.

Motoyama, Satoru

Ogata, Takashi

Kawakami, Hisato

Adenis, Antoine

Hajbi, Farid El

Bartolomeo, Maria Di

Braghiroli, Maria Ignez

Holtved, Eva

Blum Murphy, Mariela A.

Novosiadly, Ruslan

Ajani, Jaffer A.

URI

Type

journal article